Analytik Jena Buys Imaging Firm UVP | GenomeWeb

NEW YORK (GenomeWeb News) – German analytical instrument firm Analytik Jena today announced it signed a contract to acquire life science imaging company UVP for an undisclosed price.

The deal is anticipated to close April 5, and, in addition to acquiring UVP, Analytik Jena will purchase the Upland, Calif.-based company's wholly owned subsidiary Ultra-Violet Products, headquartered in Cambridge, UK.

The deal launches Analytik Jena into the US market, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.